Adult T-cell leukemia/lymphoma
MONDO:0019471A peripheral (mature) T-cell neoplasm linked to the human T-cell leukemia virus type 1 (HTLV-1), adult T-cell leukemia/lymphoma is endemic in several regions of the world, in particular Japan, the Caribbean, and parts of Central Africa.
Also known as: ATLL, T-cell leukaemia of adults, T-cell leukemia of adults, adult T-cell leukaemia, adult T-cell leukemia, adult T-cell leukemia/lymphoma, HTLV-1 associated adult T-cell lymphoma/leukemia, HTLV-I associated adult T-cell leukemia/lymphoma
1969 clinical trials for this condition and its sub-types, 31 tagged with Adult T-cell leukemia/lymphoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Experimental lymphoma drug ASTX660 tested in tiny, terminated trial
Disease control Stopped earlyThis early-phase trial tested the drug ASTX660 in just 8 people with T-cell lymphoma that had returned or not responded to prior treatments. The study aimed to find a safe dose and check for side effects, but it was stopped early. Because it was so small and incomplete, we cannot…
Phase 1/2 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Promising combo for tough blood cancers halted early — only 4 patients enrolled
Disease control Stopped earlyThis study tested whether adding rapamycin to high-dose chemotherapy could help people with aggressive blood cancers (like certain leukemias and lymphomas) that had returned or not responded to prior treatment. Only 4 adults aged 18–65 took part before the study was stopped early…
Phase 1/2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC